rpoB Mutations in Streptococcus mitis Clinical Isolates Resistant to Rifampin

Activity of rifampin against 129 Streptococcus mitis isolates obtained from patients with hematologic cancer was investigated. One hundred twenty-five strains were susceptible to rifampin, and 4 were resistant (MIC = 32 to 64 μg/ml). Resistance to rifampin was related to mutations in the rpoB gene:...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Achour, Wafa, Guenni, Olfa, Fines, Marguerite, Leclercq, Roland, Ben Hassen, Assia
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2004
Assuntos:	Mechanisms of Resistance
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC434179/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15215145/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.48.7.2757-2759.2004
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!